4951 - 4975 of 6255 Results
Title
Year
-
OPENTitle: Screening non-MAPT genes of the Chr17q21 H1 haplotype in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 78Issue #:Start Page: 138End Page: 144Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.07.022Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7686230Citation Count: 16
- Increased 14-3-3 phosphorylation observed in Parkinson's disease reduces neuroprotective potential of 14-3-3 proteins2015OPENTitle: Increased 14-3-3 phosphorylation observed in Parkinson's disease reduces neuroprotective potential of 14-3-3 proteinsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 79Issue #:Start Page: 1End Page: 13Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2015.02.032Citation Count: 41
- Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine Neurons2018OPENTitle: Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine NeuronsJournal Name: The American Journal of Human GeneticsPublisher: Elsevier BVVol: 103Issue #: 6Start Page: 874End Page: 892Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.ajhg.2018.10.018Best OA location URL: http://www.cell.com/article/S0002929718303707/pdfCitation Count: 39
-
OPENTitle: Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non‐Ashkenazi Jewish ancestryJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 10Start Page: 1432End Page: 1438Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27059Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5656509Citation Count: 147
- Development of a Positron Emission Tomography Radiotracer for Imaging Elevated Levels of Superoxide in Neuroinflammation2017OPENTitle: Development of a Positron Emission Tomography Radiotracer for Imaging Elevated Levels of Superoxide in NeuroinflammationJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 9Issue #: 3Start Page: 578End Page: 586Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.7b00385Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5865080Citation Count: 67
-
OPENTitle: No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 141Issue #: 3Start Page: e16End Page: e16Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awx378Best OA location URL: https://academic.oup.com/brain/article-pdf/141/3/e16/25046297/awx378.pdfCitation Count: 8
-
OPENTitle: Nanobodies as allosteric modulators of Parkinson’s disease–associated LRRK2Journal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 119Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2112712119Best OA location URL: https://research.rug.nl/en/publications/2dd21a81-bba8-4531-aab2-e50105663eadCitation Count: 44
-
OPENTitle: Is the MC1R variant p.R160W associated with Parkinson's?Journal Name: Annals of NeurologyPublisher: WileyVol: 79Issue #: 1Start Page: 159End Page: 161Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.24527Best OA location URL: http://doi.org/10.1002/ana.24527Citation Count: 18
-
OPENTitle: Neurophysics Assessment of the Muscle Bioenergy Generated by Transcranial Magnetic StimulationJournal Name: ResearchPublisher: American Association for the Advancement of Science (AAAS)Vol: 2019Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2019/7109535Best OA location URL: https://doi.org/10.1155/2019/7109535Citation Count: 1
- Letter in response to Cole-Hunter et al., 2023: What does “Parkinson’s disease mortality” mean?2023OPENTitle: Letter in response to Cole-Hunter et al., 2023: What does “Parkinson’s disease mortality” mean?Journal Name: Environment InternationalPublisher: Elsevier BVVol: 173Issue #:Start Page: 107852End Page: 107852Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.envint.2023.107852Best OA location URL: https://doi.org/10.1016/j.envint.2023.107852Citation Count: 1
- Silencing Alpha Synuclein in Mature Nigral Neurons Results in Rapid Neuroinflammation and Subsequent Toxicity2018OPENTitle: Silencing Alpha Synuclein in Mature Nigral Neurons Results in Rapid Neuroinflammation and Subsequent ToxicityJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2018.00036Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2018.00036/pdfCitation Count: 92
-
OPENTitle: PFTK1 kinase regulates axogenesis during development via RhoA activationJournal Name: BMC BiologyPublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12915-023-01732-wBest OA location URL: https://bmcbiol.biomedcentral.com/counter/pdf/10.1186/s12915-023-01732-wCitation Count: 2
- Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity2019OPENTitle: Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicityJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 137Issue #: 6Start Page: 939End Page: 960Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-019-01993-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-019-01993-2.pdfCitation Count: 76
-
OPENTitle: Regional volumetric change in Parkinson's disease with cognitive declineJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 373Issue #:Start Page: 88End Page: 94Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.jns.2016.12.030Best OA location URL: https://doi.org/10.1016/j.jns.2016.12.030Citation Count: 27
- Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages2022OPENTitle: Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophagesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00297-9Best OA location URL: https://www.nature.com/articles/s41531-022-00297-9.pdfCitation Count: 33
- Loss of kallikrein‐related peptidase 7 exacerbates amyloid pathology in Alzheimer's disease model mice2018OPENTitle: Loss of kallikrein‐related peptidase 7 exacerbates amyloid pathology in Alzheimer's disease model miceJournal Name: EMBO Molecular MedicinePublisher: Springer Science and Business Media LLCVol: 10Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/emmm.201708184Best OA location URL: https://doi.org/10.15252/emmm.201708184Citation Count: 47
-
OPENTitle: CoolMPS: evaluation of antibody labeling based massively parallel non-coding RNA sequencingJournal Name: Nucleic Acids ResearchPublisher: Oxford University Press (OUP)Vol: 49Issue #: 2Start Page: e10End Page: e10Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/nar/gkaa1122Best OA location URL: https://academic.oup.com/nar/article-pdf/49/2/e10/36084915/gkaa1122.pdfCitation Count: 14
-
OPENTitle: Changes in kynurenine pathway metabolism in Parkinson patients with L‐DOPA‐induced dyskinesiaJournal Name: Journal of NeurochemistryPublisher: WileyVol: 142Issue #: 5Start Page: 756End Page: 766Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.14104Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.14104Citation Count: 102
- RAB7L1-Mediated Relocalization of LRRK2 to the Golgi Complex Causes Centrosomal Deficits via RAB8A2018OPENTitle: RAB7L1-Mediated Relocalization of LRRK2 to the Golgi Complex Causes Centrosomal Deficits via RAB8AJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2018.00417Best OA location URL: https://doi.org/10.3389/fnmol.2018.00417Citation Count: 43
- Antipsychotic drug efficacy correlates with the modulation of D1 rather than D2 receptor-expressing striatal projection neurons2023OPENTitle: Antipsychotic drug efficacy correlates with the modulation of D1 rather than D2 receptor-expressing striatal projection neuronsJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 26Issue #: 8Start Page: 1417End Page: 1428Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41593-023-01390-9Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10842629Citation Count: 49
-
OPENTitle: Exploring the early drivers of pain in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41598-025-90678-wBest OA location URL: https://www.nature.com/articles/s41598-025-90678-w.pdfCitation Count: 0
-
OPENTitle: Disease progression models for dominantly-inherited Alzheimer’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 141Issue #: 5Start Page: 1244End Page: 1246Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awy089Best OA location URL: https://academic.oup.com/brain/article-pdf/141/5/1244/25083196/awy089.pdfCitation Count: 2
- Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's disease2018OPENTitle: Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 112Issue #:Start Page: 136End Page: 148Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.nbd.2018.01.004Best OA location URL: https://repositorio.uchile.cl/handle/2250/167345Citation Count: 145
-
OPENTitle: Understanding what aspects of Parkinson’s disease matter most to patients and familiesJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41598-024-71555-4Best OA location URL: https://doi.org/10.1038/s41598-024-71555-4Citation Count: 8
- A Comparative Study of High-Contrast Fluorescence Lifetime Probes for Imaging Amyloid in Tissue2021OPENTitle: A Comparative Study of High-Contrast Fluorescence Lifetime Probes for Imaging Amyloid in TissueJournal Name: The Journal of Physical Chemistry BPublisher: American Chemical Society (ACS)Vol: 125Issue #: 50Start Page: 13710End Page: 13717Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jpcb.1c07762Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7615715Citation Count: 6